Insulin initiation and intensification in patients with T2DM for the primary care physician
Jeff UngerCatalina Research Institute, Chino, CA, USAAbstract: Type 2 diabetes mellitus (T2DM) is characterized by both insulin resistance and inadequate insulin secretion. All patients with the disease require treatment to achieve and maintain the target glycosylated hemoglobin (A1C) level of 6.5%&...
Guardado en:
Autor principal: | Unger J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18ae5305ed3245389ab9bc85a2ed23da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
por: Kostev K, et al.
Publicado: (2015) -
Genetic variants linked to T2DM risk in Kurdish populations [Retraction]
por: Golsheh S, et al.
Publicado: (2019) -
Comorbidity and glycemia control among patients with type 2 diabetes in primary care
por: Catherine Hudon, et al.
Publicado: (2008) -
Insulin detemir for the treatment of obese patients with type 2 diabetes
por: Hollander PA
Publicado: (2012) -
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
por: Wilke T, et al.
Publicado: (2019)